Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
01 1COLESEVELAM HYDROCHLORIDE
02 1OMEPRAZOLE AND SODIUM BICARBONATE
03 1RELYVRIO
04 1REVATIO
05 3SILDENAFIL CITRATE
06 2SUPRAX
01 165355
02 179182
03 1202091
04 1202190
05 1203109
06 1211638
07 1212440
08 1215708
09 1216660
01 7No
02 2Yes
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
OMEPRAZOLE; SODIUM BICARBONATE
Drug : OMEPRAZOLE AND SODIUM BICARBONATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 79182
Country : US
Patented : No
Drug : SILDENAFIL CITRATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 212440
Country : US
Patented : No
SODIUM PHENYLBUTYRATE; TAURURSODIOL
Drug : RELYVRIO
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 216660
Country : US
Patented : Yes
Drug : COLESEVELAM HYDROCHLORIDE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 202190
Country : US
Patented : No
Drug : SILDENAFIL CITRATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 211638
Country : US
Patented : No
Drug : SUPRAX
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 202091
Country : US
Patented : Yes
Drug : SUPRAX
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 65355
Country : US
Patented : No
Drug : REVATIO
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 203109
Country : US
Patented : No
Drug : SILDENAFIL CITRATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 215708
Country : US
Patented : No
